Evan Shereck
Overview
Explore the profile of Evan Shereck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
436
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Schoemans H, Finn L, Foster J, Roche-Green A, Bevans M, Kullberg S, et al.
Biol Blood Marrow Transplant
. 2019 Feb;
25(7):1416-1423.
PMID: 30796997
Patient, caregiver, and family education and support was 1 of 6 key areas of interest identified by the National Marrow Donor Program/Be The Match 2-year project to prioritize patient-centered outcomes...
12.
Winsnes K, Sochacki P, Eriksson C, Shereck E, Recht M, Johnson K, et al.
Pediatr Blood Cancer
. 2019 Jan;
66(6):e27640.
PMID: 30697919
Background: Delirium affects 10% to 30% of patients in pediatric intensive care units (PICU) and is associated with increased length of stay and prolonged late sequela. There are no prospective...
13.
Dvorak C, Haddad E, Buckley R, Cowan M, Logan B, Griffith L, et al.
J Allergy Clin Immunol
. 2018 Sep;
143(1):405-407.
PMID: 30193840
No abstract available.
14.
Haddad E, Logan B, Griffith L, Buckley R, Parrott R, Prockop S, et al.
Blood
. 2018 Aug;
132(17):1737-1749.
PMID: 30154114
The Primary Immune Deficiency Treatment Consortium (PIDTC) performed a retrospective analysis of 662 patients with severe combined immunodeficiency (SCID) who received a hematopoietic cell transplantation (HCT) as first-line treatment between...
15.
Heimall J, Logan B, Cowan M, Notarangelo L, Griffith L, Puck J, et al.
Blood
. 2017 Oct;
130(25):2718-2727.
PMID: 29021228
The Primary Immune Deficiency Treatment Consortium (PIDTC) is enrolling children with severe combined immunodeficiency (SCID) to a prospective natural history study. We analyzed patients treated with allogeneic hematopoietic cell transplantation...
16.
Kesselheim J, Agrawal A, Bhatia N, Cronin A, Jubran R, Kent P, et al.
Pediatr Blood Cancer
. 2016 Nov;
64(5).
PMID: 27808467
Background: Educators in pediatric hematology-oncology lack rigorously developed instruments to assess fellows' skills in humanism and professionalism. Procedure: We developed a novel 15-item self-assessment instrument to address this gap in...
17.
Spavor M, Halton J, Dietrich K, Israels S, Shereck E, Yong J, et al.
Thromb Res
. 2016 Jun;
144:27-31.
PMID: 27270219
Introduction: Pediatric oncology patients are at increased risk for deep venous thrombosis (DVT). Determining the sub-population of children at increased DVT risk is critical for optimum clinical management. Therefore, the...
18.
Kesselheim J, Atlas M, Adams D, Aygun B, Barfield R, Eisenman K, et al.
Pediatr Blood Cancer
. 2014 Oct;
62(2):335-340.
PMID: 25307425
Background: Humanism and professionalism are virtues intrinsic to the practice of medicine, for which we lack a standard, evidence-based approach for teaching and evaluation. Pediatric hematology-oncology (PHO) fellowship training brings...
19.
Burns L, Gajewski J, Majhail N, Navarro W, Perales M, Shereck E, et al.
Biol Blood Marrow Transplant
. 2014 Feb;
20(5):617-21.
PMID: 24508838
Hematopoietic cell transplantation (HCT) remains the only known curative therapy for many patients with hematologic, metabolic, and immunologic disorders. Furthermore, the use of HCT has increased with the emergence of...
20.
Shereck E, Shenoy S, Pulsipher M, Burns L, Bracey A, Chell J, et al.
Biol Blood Marrow Transplant
. 2013 Jul;
19(9):1399-402.
PMID: 23838095
The National Marrow Donor Program (NMDP) projects the need for allogeneic unrelated blood and marrow transplantation (BMT) in the United States as 10,000 per year. Although the NMDP is preparing...